Amersham, United Kingdom

James Nairne

This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Ge Healthcare Limited. Active years: 2015.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Nairne: Innovator in Imaging Probes for Alzheimer's Disease

Introduction

James Nairne is a notable inventor based in Amersham, GB. He has made significant contributions to the field of medical imaging, particularly in relation to Alzheimer's disease. His work focuses on developing innovative compounds that can aid in the diagnosis and understanding of tau pathology.

Latest Patents

James Nairne holds a patent for "Heterocyclic compounds as imaging probes of tau pathology." This patent describes heterocyclic compounds of formula (I) that are useful as imaging probes for tau pathology in Alzheimer's disease. The patent also outlines the compositions and methods for making such compounds, showcasing his commitment to advancing medical technology.

Career Highlights

James Nairne is associated with GE Healthcare Limited, a company renowned for its contributions to healthcare technology. His role at GE Healthcare Limited allows him to work on cutting-edge innovations that have the potential to improve patient outcomes.

Collaborations

Throughout his career, James has collaborated with talented individuals such as Clare Louise Jones and Amanda Ewan. These collaborations have likely enriched his research and contributed to the development of his patented technologies.

Conclusion

James Nairne's work in developing imaging probes for Alzheimer's disease represents a significant advancement in medical research. His innovative approach and collaboration with other professionals highlight the importance of teamwork in the field of healthcare technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…